RT Journal Article
SR Electronic
T1 Detection of SARS-CoV-2 in ascitic fluid: a case of viral peritonitis?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.25.20139998
DO 10.1101/2020.06.25.20139998
A1 Victor C. Passarelli
A1 Ana H. Perosa
A1 Luciano Luna
A1 Danielle D. Conte
A1 Oliver A. Nascimento
A1 Jaquelina Ota-Arakaki
A1 Nancy Bellei
YR 2020
UL http://medrxiv.org/content/early/2020/07/22/2020.06.25.20139998.abstract
AB SARS Coronavirus-2 detection in different clinical specimens, including serum and stool, has raised important insights about its dynamics and pathogenesis, but some details remain to be understood.In that respect, disrupt viral control seen in immunocompromising conditions can help unveil pathogenetic mechanisms and characterize new Coronavirus Disease-19 immunological and clinical aspects in general.We herein report a case of cirrhosis decompensation with ascites due to COVID-19 and unprecedented detection of SARS-CoV-2 in ascitic fluid, hence a possible acute viral peritonitis, as well as in serum, leading to a fatal disseminated infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received support from the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES) and the National Council for Scientific and Technological Development (CNPq). No financial grants were received for the research, authorship or publication of this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This case report was approved by Local Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNone.